These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38029507)
1. The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer. Zhao YC; Wang TJ; Cui J; She LZ; Zhang RF; Zhang CH Transl Oncol; 2024 Feb; 40():101839. PubMed ID: 38029507 [TBL] [Abstract][Full Text] [Related]
2. SERPINB7 as a prognostic biomarker in cervical cancer: Association with immune infiltration and facilitation of the malignant phenotype. Wei HF; Zhang RF; Zhao YC; Tong XS Heliyon; 2023 Sep; 9(9):e20184. PubMed ID: 37809412 [TBL] [Abstract][Full Text] [Related]
3. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998 [TBL] [Abstract][Full Text] [Related]
4. S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior Zhao YC; Wang TJ; She LZ; Cui J; Zhang CH J Cancer; 2023; 14(15):2931-2945. PubMed ID: 37781076 [No Abstract] [Full Text] [Related]
5. SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration. Zhao YC; Li YF; Qiu L; Jin SZ; Shen YN; Zhang CH; Cui J; Wang TJ BMC Cancer; 2024 Sep; 24(1):1133. PubMed ID: 39261819 [TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer. Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071 [TBL] [Abstract][Full Text] [Related]
7. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration. Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559 [No Abstract] [Full Text] [Related]
10. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. Wu C; Ma C; Yuan J; Zhou P Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164 [No Abstract] [Full Text] [Related]
12. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification. Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026 [TBL] [Abstract][Full Text] [Related]
13. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis. Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467 [TBL] [Abstract][Full Text] [Related]
14. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Xu HH; Wang HL; Xing TJ; Wang XQ Front Immunol; 2022; 13():851622. PubMed ID: 35924232 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. Xing C; Yin H; Yao ZY; Xing XL Front Oncol; 2021; 11():774558. PubMed ID: 35087751 [TBL] [Abstract][Full Text] [Related]
16. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer. Lu X; Li R; Ying Y; Zhang W; Wang W J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934 [TBL] [Abstract][Full Text] [Related]
17. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer. Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503 [No Abstract] [Full Text] [Related]
18. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma. Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242 [TBL] [Abstract][Full Text] [Related]
19. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification. Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148 [TBL] [Abstract][Full Text] [Related]
20. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer. Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]